HA’s Medical Advisory Board Issues New Statements Regarding COVID-19
In a recent meeting, the Hydrocephalus Association (HA)’s Medical Advisory Board (MAB) issued two new consensus statements regarding COVID-19.
COVID Vaccination for Children with Hydrocephalus
Consistent with CDC and FDA guidance, the Medical Advisory Board encourages parents to obtain a COVID vaccination for their children with hydrocephalus, provided they have no other medical conditions that their primary care providers or other treating physicians consider to be a medical contraindication to the vaccine.
COVID Boosters for Individuals with Hydrocephalus
Consistent with CDC and FDA guidance, the Medical Advisory Board encourages persons with hydrocephalus and their families to receive the COVID-19 booster vaccination when they become eligible according to federal, state, and local guidelines, provided they have
no medical conditions that their primary care providers or other treating physicians consider to be a medical contraindication to the booster vaccine.
HA receives questions or requests from our community for information on various topics, ranging from medical issues to lifestyle. To address these topics, the MAB occasionally issues consensus statements based on a combination of expert opinion, review of research literature, and review of guidance from respected and reliable authorities, such as the FDA, NIH, or CDC.
HA’s Medical Advisory Board is an independent advisory board to the HA Board of Directors and staff. The MAB Is composed of 25 leading medical professionals who serve hydrocephalus patients and families across the United States and Canada. The MAB is a multidisciplinary group, composed of neurosurgeons, neurologists, neuropsychologists, and advanced practice providers. A key role of the MAB is to assist in the development of HA educational materials and review of HA literature, resource materials, and newsletter articles for accuracy and timeliness, allowing our community to trust the information disseminated by HA.
For more information visit our COVID-19 Guidance for People Living with Hydrocephalus page.